Groowe Groowe / Newsroom / ZBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ZBIO News

Zenas BioPharma, Inc. Common Stock

Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis

globenewswire.com
ZBIO